Health
China’s Clover says its COVID-19 vaccine candidate shows immune response in mice – Reuters
Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against…
Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against the original strain of the virus and some variants during animal testing.
Clover said in a statement its vaccine candidate demonstrated a “neutralisation” against the South African, Brazilian and UK variants among mice.
The company is testing a COVID-19 vaccine candidate containing an adjuvant, typically designed to boost the efficacy…
-
Noosa News10 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General19 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News24 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace
-
General20 hours agoSharp rise in airfares push UK inflation higher in July